IN-DATE
RBYLP0204: Penumbra Ruby Coil, Low Profile, 2mm x 4cm
Sign in to add this product to your favorites!
| Price: | $899.00 $719.20 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 4 box of 1 |
| Expiration: | 05-2027 |
| Express: | Need it tomorrow? Order in next 8 hours 47 minutes and choose overnight shipping at checkout. |
Additional Details
Penumbra Ruby Embolization Coil LP Low Profile
- Low Profile
- Deliverable through low profile microcatheters (0.0165″–0.021″)
AccessGUDID Info
- FDA Product Code: HCG
- FDA Product Code Name: DEVICE, NEUROVASCULAR EMBOLIZATION
- GMDN Term Code: 60941
- GMDN Term Name: Non-neurovascular embolization coil
- GMDN Term Description: A non-bioabsorbable, implantable device intended to induce a thrombosis within a non-neurovascular blood vessel to treat an aneurysm and/or non-neurovascular arteriovenous malformation (AVM); it is not intended for neurovascular application. It is in the form of a metal or metal/synthetic polymer wire which coils upon deployment within an aneurysm or the vasculature surrounding a malformation; it is typically pre-attached to a nonimplantable delivery wire. Disposable devices associated with implantation (e.g., delivery wire, catheter) may be included.
- GMDN Term Code: 60940
- GMDN Term Name: Neurovascular embolization coil
- GMDN Term Description: A non-bioabsorbable, implantable device intended to induce a neurovascular thrombosis to treat an intracranial aneurysm and/or neurovascular arteriovenous malformation (AVM); it may also be intended to treat non-neurovascular malformations. It is in the form of a metal [e.g., platinum alloy] or metal/synthetic polymer wire which coils upon deployment within the aneurysm/vasculature; it is typically pre-attached to a nonimplantable delivery wire. Disposable devices associated with implantation (e.g., delivery wire, catheter) may be included.
Manufacturer
Penumbra is a global healthcare company focused on innovative therapies for neuro and vascular conditions, with a strong emphasis on stroke care and peripheral interventions. Best known for its aspiration-based thrombectomy systems, Penumbra’s portfolio includes the Penumbra System for mechanical clot removal in acute ischemic stroke, and the Indigo System for peripheral arterial and venous thrombectomy. The company has also expanded into interventional embolization with its POD and Ruby coil platforms, as well as real-time imaging technologies like the Lightning Intelligent Aspiration system. With a growing presence in immersive healthcare technologies and rehabilitation, Penumbra continues to advance minimally invasive solutions that improve outcomes across neurovascular and peripheral vascular care.
